Fennec Pharmaceuticals Inc. · NASDAQ:FENC

Evans Terry L received 168 Fennec Pharmaceuticals Inc. shares as an award (Form 4)

Traded Oct 31, 2026 · Filed Nov 2, 2026

On Oct 31, 2026, Evans Terry L (Chief Commercial Officer) received 168 Fennec Pharmaceuticals Inc. shares as an award, leaving 24,181 shares. Filed Nov 2, 2026 (Form 4).

Awarded
168 shares
Holding after
24,181 shares
Trading plan
No
Role
Chief Commercial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Oct 31, 2026Common SharesAward16824,181Direct

Source

Download original · View original at SEC

Related